Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Asset / Drug

Feasibility

Drug and asset intelligence for Feasibility with 7 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
7
Catalysts
0
Stage
Development stage unavailable

Mechanism of action

Radiotherapy

Recent signals(7)

ClinicalAugust 4, 2026

Feasibility Study of UP-A-AST for Adolescents with Autism and Anxiety/Depression

A study is evaluating the feasibility and effects of the UP-A-AST Parent Group for adolescents with ASD and co-occurring anxiety/depression.

ClinicalJuly 19, 2026

Feasibility Study on IRE System for Adenotonsillar Hypertrophy in Children

A multi-center feasibility study is underway to assess the safety and efficacy of the IRE System for treating adenotonsillar hypertrophy in children.

ClinicalJuly 3, 2026

Feasibility Study of RestoreMe App for Cancer Patient Nutrition and Activity

Montefiore Medical Center is conducting a feasibility study to assess the RestoreMe app for cancer patients, recruiting 150 participants.

ClinicalJune 29, 2026

Feasibility Study of IV Contrast-Enhanced CBCT in Radiotherapy

A single-arm feasibility study is evaluating the use of intravenous contrast-enhanced CBCT for image guidance in radiotherapy.

ClinicalJune 27, 2026

Feasibility Study for Platform Trial in Intracerebral Haemorrhage Patients

The University of Edinburgh is conducting a feasibility study to evaluate a platform trial design for adults with stroke due to intracerebral haemorrhage.

ClinicalJune 24, 2026

Feasibility Study on Olfactory Stimuli in VR for Alcohol Dependence Patients

A feasibility study is evaluating the integration of olfactory stimuli into virtual reality cue exposure for alcohol dependence.

ClinicalJune 24, 2026

Feasibility Trial for Drug Repurposing in Advanced Thyroid Cancer Initiated

A phase Ib trial is underway to assess the feasibility of personalized drug repurposing in advanced thyroid cancer patients.

Upcoming milestones

No catalysts indexed for this entity yet.

Related catalysts

No catalysts indexed for this entity yet.

Indications

Autism Spectrum Disorder →
Thyroid Carcinoma →

Therapeutic areas

Addiction →
Alcohol Dependence →
Autism Spectrum Disorder →
ENT →
Neurology →
Oncology →
Psychiatry →
Radiotherapy →
Stroke →
Supportive Care →
Surgical Intervention →
Thyroid Carcinoma →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.